NoNO Inc. has developed and autoinjector compatible PSD95 inhibitor to provide neuroprotection that can be administered by any caregiver at home, enroute to the hospital or immediately upon arrival in...
NoNO Inc.
5 enregistrements totalisant 1,972,643.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Conseil national de recherches Canada | $1,972,643 | 5 enregistrements |
Enregistrements
This proposal focuses on translating academic discoveries into new treatments for stroke recovery and chronic neurological diseases that constitute massive socioeconomic burdens in Canada and worldwid...
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided from the IAP program is to assist innovative, early stage small-and medium-sized enterprises that are unable to access existing COVID-19 business support.
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.